PRECLINICAL STUDY
Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by n-3 Polyunsaturated Fatty Acids in Dogs
Jean-Francois Sarrazin, MD*,
Genevieve Comeau, MSc*,
Pascal Daleau, PhD*, ,
John Kingma, PhD*, ,
Isabelle Plante, PhD*,
Dominique Fournier, MSc* and
Franck Molin, MD*,,*
* Institut Universitaire de Cardiologie et Pneumologie, Quebec, Canada
Faculty of Pharmacy, Laval University, Quebec, Canada
Faculty of Medicine, Laval University, Quebec, Canada.
Manuscript received February 14, 2007;
revised manuscript received April 30, 2007,
accepted May 1, 2007.
* Reprint requests and correspondence: Dr. Franck Molin, Institut Universitaire de Cardiologie et Pneumologie, 2725, Chemin Sainte Foy, Quebec, G1V 4G5 Canada. (Email: franck.molin{at}med.ulaval.ca).
Objectives: This open-label canine study assessed whether n-3 polyunsaturated fatty acids (PUFAs) prevent vagally induced atrial fibrillation (AF) and influence atrial tissue expression levels of connexins (CXs).
Background: n-3 polyunsaturated fatty acids in fish oils protect against sudden cardiac death and reduce postoperative AF. Changes in spatial organization of gap junctions or cellular CX levels have been linked to arrhythmogenesis.
Methods: Vagally induced AF was studied. Eight dogs were given fish oil daily for 14 days. Eight control dogs had reproducibly induced AF and were re-evaluated after intravenous administration of fish oil. Atrial fibrillation was compared, and n-3 PUFA, CX40, and CX43 protein levels were assessed in atrial biopsies.
Results: Atrial tissue n-3 PUFA levels increased in oral treatment dogs (5.78 ± 0.71% vs. 2.49 ± 0.46% in control animals, p < 0.001). No difference was observed for atrial refractory periods or hemodynamic or electrocardiographic parameters. Incidence of AF in oral treatment dogs decreased 79% with the extra stimulus technique (10.5% vs. 48.9%, p = 0.003) and 42% with burst induction (22.5% vs. 38.8%, p = 0.038). Both CX40 and CX43 levels were lower in oral treatment dogs (60% [p = 0.019] and 42% [p = 0.038] lower, respectively); protection against AF was mostly related to reduced CX40 expression levels (p = 0.02). In dogs that were given intravenous n-3 PUFAs, AF inducibility by the extra stimulus technique was reduced from 75.0% to 28.6% (p = 0.002).
Conclusions: Oral treatment with fish oils increased atrial n-3 PUFA levels and reduced vulnerability to induction of AF in this dog model. Modulation of cardiac CX by n-3 PUFAs probably contributes to the antiarrhythmic effects of fish oils.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | BCL = basic cycle length | | CX = connexin | | DHA = docosahexaenoic acid | | EPA = eicosapentaenoic acid | | ERP = effective refractory period | | HR = heart rate | | PAC = premature atrial complex | | PUFA = polyunsaturated fatty acid |
|
Related Article
-
Fish Oil and Prevention of Atrial Fibrillation
- Dariush Mozaffarian
J. Am. Coll. Cardiol. 2007 50: 1513-1514.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
D. Mozaffarian and J. H. Y. Wu
Omega-3 Fatty Acids and Cardiovascular Disease: Effects on Risk Factors, Molecular Pathways, and Clinical Events
J. Am. Coll. Cardiol.,
November 8, 2011;
58(20):
2047 - 2067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, and L. Dei Cas
n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion: A Prospective, Randomized Study
Circulation,
September 6, 2011;
124(10):
1100 - 1106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kitamura, R. Shibata, Y. Tsuji, M. Shimano, Y. Inden, and T. Murohara
Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model
Am J Physiol Heart Circ Physiol,
May 1, 2011;
300(5):
H1814 - H1821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Tuomi, K. Tyml, and D. L. Jones
Atrial tachycardia/fibrillation in the connexin 43 G60S mutant (Oculodentodigital dysplasia) mouse
Am J Physiol Heart Circ Physiol,
April 1, 2011;
300(4):
H1402 - H1411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Savelieva, N. Kakouros, A. Kourliouros, and A. J. Camm
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
Europace,
March 1, 2011;
13(3):
308 - 328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Bianconi, L. Calo, M. Mennuni, L. Santini, P. Morosetti, P. Azzolini, G. Barbato, F. Biscione, P. Romano, and M. Santini
n-3 Polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study
Europace,
February 1, 2011;
13(2):
174 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Kowey, J. A. Reiffel, K. A. Ellenbogen, G. V. Naccarelli, and C. M. Pratt
Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial
JAMA,
December 1, 2010;
304(21):
2363 - 2372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Heidarsdottir, D. O. Arnar, G. V. Skuladottir, B. Torfason, V. Edvardsson, G. Gottskalksson, R. Palsson, and O. S. Indridason
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Europace,
March 1, 2010;
12(3):
356 - 363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-M. Chaldoupi, P. Loh, R. N.W. Hauer, J. M.T. de Bakker, and H. V.M. van Rijen
The role of connexin40 in atrial fibrillation
Cardiovasc Res,
October 1, 2009;
84(1):
15 - 23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Rennison and D. R. Van Wagoner
Impact of Dietary Fatty Acids on Cardiac Arrhythmogenesis
Circ Arrhythm Electrophysiol,
August 1, 2009;
2(4):
460 - 469.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
J. Am. Coll. Cardiol.,
February 26, 2008;
51(8):
793 - 801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Mozaffarian
Fish Oil and Prevention of Atrial Fibrillation
J. Am. Coll. Cardiol.,
October 9, 2007;
50(15):
1513 - 1514.
[Full Text]
[PDF]
|
|
|
|
